Bantounou, Maria A.Plascevic, JosipMacDonald, LewisWong, Man ChunO'Connell, NeasaGalley, Helen2023-11-282023-11-282023-12-01Bantounou, M A, Plascevic, J, MacDonald, L, Wong, M C, O'Connell, N & Galley, H 2023, 'Enfortumab Vedotin and Pembrolizumab as Monotherapies and Combination Treatment in Locally Advanced or Metastatic Urothelial Carcinoma : A Narrative Review', Current Urology , vol. 17, no. 4, pp. 271-279. https://doi.org/10.1097/CU9.00000000000002041661-7657https://hdl.handle.net/2164/22287Funding Information: Supported by the National Cancer Institute of the National Institutes of Health under Award No. K12CA076917 (C.J.H.). Supported in part by National Cancer Institute Cancer Center Support grant No. P30 CA008748.9403663engSDG 3 - Good Health and Well-beingUrothelial carcinomaBladderReviewAntibodyR MedicineRJournal article10.1097/CU9.0000000000000204http://www.scopus.com/inward/record.url?scp=85139018096&partnerID=8YFLogxK174